In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
The US Environmental Protection Agency (EPA) is hard at work finalizing a new proposed rule that could affect public health negatively.
The Endocrine Society has objected the US Department of Health & Human Services’ update to the Title X Family Planning Program.
Researchers compared long-acting reversible contraceptive insertion rates in the 30 days before and after the 2016 presidential election.
Clinicians must weigh the benefits and challenges linked with self-disclosure of immigration status.
Despite giving birth to children who are American citizens, undocumented women struggle to receive adequate prenatal care.
Navigating the dichotomy between providing quality health care and dealing with a patient’s reality can be a challenge.
As the Trump White House continues to enact its approach to immigration, it’s important for physicians to apply principles of sanctuary doctoring to help patients feel safe.
As the government shutdown drags in to its second month, physicians who treat opioid use disorders are being backed against a wall.
Due to the federal government shutdown, the US Food and Drug Administration has only about 5 weeks of funding left to review new drug applications.
